Literature DB >> 2242963

Routine screening for potential babesicides using cultures of Babesia bovis.

S E Nott1, W J O'Sullivan, A M Gero, A S Bagnara.   

Abstract

A procedure for screening of potential anti-malarial agents, based on the incorporation of [3H]hypoxanthine by the parasite, was adapted for the testing of anti-metabolites against Babesia bovis (Lismore and Samford isolates) cultured in vitro. A close correlation was found between [3H]hypoxanthine incorporation in a standard assay and percentage of parasitized cells as determined by microscopic examination. The concentrations of compounds causing 50% inhibition of [3H]hypoxanthine incorporation (ID50 values) for the established babesicides, Imidocarb and Amicarbalide, were determined to be 3 ng ml-1 (8.6 nM) and 5-10 ng ml-1 (17-34 nM), respectively. A variety of other anti-metabolites were tested in the system. ID50 values for some of the more effective compounds were tubercidin (75 nM), tetracycline (25 microM), menoctone (100 nM) and TN 108, a di-Mannich base derived from 4-(7'-trifluoromethyl-quinolin-4'-ylamino)phenol (0.13 microM). No significant differences between results with the two isolates of B. bovis were observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242963     DOI: 10.1016/0020-7519(90)90014-e

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  5 in total

1.  In vitro evaluation of drug susceptibilities of Babesia divergens isolates.

Authors:  P Brasseur; S Lecoublet; N Kapel; L Favennec; J J Ballet
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Extensive Shared Chemosensitivity between Malaria and Babesiosis Blood-Stage Parasites.

Authors:  Aditya S Paul; Cristina K Moreira; Brendan Elsworth; David R Allred; Manoj T Duraisingh
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

3.  Apicoplast-targeting antibacterials inhibit the growth of Babesia parasites.

Authors:  Mahmoud Aboulaila; Tserendorj Munkhjargal; Thillaiampalam Sivakumar; Akio Ueno; Yuki Nakano; Miki Yokoyama; Takeshi Yoshinari; Daisuke Nagano; Koji Katayama; Nasr El-Bahy; Naoaki Yokoyama; Ikuo Igarashi
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

4.  Assessment of Draxxin® (tulathromycin) as an inhibitor of in vitro growth of Babesia bovis, Babesia bigemina and Theileria equi.

Authors:  Marta G Silva; Nicolas F Villarino; Donald P Knowles; Carlos E Suarez
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-04-17       Impact factor: 4.077

Review 5.  Unravelling the cellular and molecular pathogenesis of bovine babesiosis: is the sky the limit?

Authors:  Carlos E Suarez; Heba F Alzan; Marta G Silva; Vignesh Rathinasamy; William A Poole; Brian M Cooke
Journal:  Int J Parasitol       Date:  2019-01-26       Impact factor: 3.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.